DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Sells 83,033 Shares of The Clorox Company (NYSE:CLX)

DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lowered its stake in shares of The Clorox Company (NYSE:CLX) by 31.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 177,464 shares of the company’s stock after selling 83,033 shares during the quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main’s holdings in Clorox were worth $28,822,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the stock. Integral Investment Advisors Inc. grew its holdings in shares of Clorox by 4.1% during the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after acquiring an additional 67 shares during the period. HCR Wealth Advisors grew its stake in Clorox by 1.0% in the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after purchasing an additional 68 shares during the period. Sound View Wealth Advisors Group LLC grew its stake in Clorox by 6.1% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock worth $218,000 after purchasing an additional 77 shares during the period. Wedbush Securities Inc. raised its holdings in Clorox by 1.2% in the fourth quarter. Wedbush Securities Inc. now owns 7,624 shares of the company’s stock worth $1,238,000 after purchasing an additional 94 shares in the last quarter. Finally, Brooklyn Investment Group lifted its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the period. 78.53% of the stock is owned by institutional investors.

Clorox Stock Performance

Shares of NYSE CLX opened at $137.75 on Friday. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The firm has a market capitalization of $16.97 billion, a price-to-earnings ratio of 37.64, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The firm has a 50 day moving average of $142.69 and a 200 day moving average of $154.27.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The company’s revenue was down 8.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.71 EPS. On average, research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.54%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s dividend payout ratio is 87.61%.

Analyst Ratings Changes

CLX has been the topic of a number of recent research reports. Wells Fargo & Company reduced their target price on shares of Clorox from $145.00 to $142.00 and set an “equal weight” rating on the stock in a research report on Tuesday. DA Davidson cut their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. UBS Group lowered their target price on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a report on Thursday, April 17th. Evercore ISI set a $140.00 price target on Clorox and gave the stock an “underperform” rating in a research note on Tuesday. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $151.23.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.